Endocrine Abstracts

Objective: Nation-wide reimbursement of intermittently scanned continuous glucose monitoring (isCGM) for people with type 1 diabetes was introduced in Belgium in 2016. We investigated whether diabetes knowledge and health literacy would impact glycemic control after one year of isCGM use.Research design and methods: In this substudy of the FUTURE trial, a prospective observational real-world cohort study in individuals with type 1 diabetes ≥16 year...

Background and Aims: To evaluate whether switching from traditional mealtime insulin analogs to fast-acting insulin aspart (Fiasp) in routine clinical practice is efficacious and safe in adult people with type 1 diabetes (PWD1) using intermittent or real-time continuous glucose monitoring (iCGM or rtCGM).Methods: Data from 438 adult PWD1 (60% men, age 44.6±16.1 years, duration of diabetes 21.5±14.0 years, iCGM/rtCGM: 391/47, injections/pump: 409/29...